These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23965404)

  • 1. A case of severe chronic progressive axonal polyradiculoneuropathy temporally associated with anti-CV2/CRMP5 antibodies.
    Hannawi Y; Goldsmith CE; Kass JS; Olar A; Ubogu EE; Kalkonde YV
    J Clin Neuromuscul Dis; 2013 Sep; 15(1):13-8. PubMed ID: 23965404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
    Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphiphysin-IgG autoimmune neuropathy: A recognizable clinicopathologic syndrome.
    Dubey D; Jitprapaikulsan J; Bi H; Do Campo RV; McKeon A; Pittock SJ; Engelstad JK; Mills JR; Klein CJ
    Neurology; 2019 Nov; 93(20):e1873-e1880. PubMed ID: 31624089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic Syndrome Presenting Combined Central and Peripheral Demyelination Associated with Anti-CV2/CRMP5 and Anti-NF186 Antibodies: A Case Report.
    Liu B; Zhou L; Zheng Y; Sun C; Lin J
    Brain Sci; 2023 Feb; 13(3):. PubMed ID: 36979184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls in the detection of CV2 (CRMP5) antibodies.
    Sabater L; Saiz A; Dalmau J; Graus F
    J Neuroimmunol; 2016 Jan; 290():80-3. PubMed ID: 26711575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.
    Dubey D; Lennon VA; Gadoth A; Pittock SJ; Flanagan EP; Schmeling JE; McKeon A; Klein CJ
    Neurology; 2018 Jan; 90(2):e103-e110. PubMed ID: 29222126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic chorea and behavioral disorders in a patient with anti-CV2/CRMP5 antibodies and two different tumors].
    Ritzenthaler T; Verret JM; Honnorat J
    Rev Neurol (Paris); 2010 Jan; 166(1):90-5. PubMed ID: 19497605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature.
    Jarius S; Wandinger KP; Borowski K; Stoecker W; Wildemann B
    Clin Neurol Neurosurg; 2012 May; 114(4):331-5. PubMed ID: 22138095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
    Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
    Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic Choreoathetosis in a Patient with Small Cell Lung Carcinoma and Anti-CRMP5/CV2: A Case Report.
    Aydin D; Somnier F; Lassen LH
    Case Rep Neurol; 2016; 8(1):16-9. PubMed ID: 26889151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral neuropathies associated with antibodies directed to intracellular neural antigens.
    Antoine JC
    Rev Neurol (Paris); 2014 Oct; 170(10):570-6. PubMed ID: 25194475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CV2/CRMP5 antibody-associated hemorrhagic leukoencephalomyelitis treated with steroids, intravenous immunoglobulin, plasmapheresis, and cyclophosphamide.
    Chu L; Clift F
    Mult Scler Relat Disord; 2020 May; 40():101964. PubMed ID: 32044694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes.
    Wang S; Hou H; Tang Y; Zhang S; Wang G; Guo Z; Zhu L; Wu J
    Neural Regen Res; 2023 Nov; 18(11):2357-2364. PubMed ID: 37282453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CV2/CRMP5 Paraneoplastic Chorea Effectively Managed with Intravenous Amantadine.
    Ha J; Na BS; Ahn JH; Kim M; Kim JW; Lee JH; Cho JW; Kim JS; Youn J
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31656691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CV2 autoantibodies and paraneoplastic neurological syndromes.
    Rogemond V; Honnorat J
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):51-9. PubMed ID: 11064826
    [No Abstract]   [Full Text] [Related]  

  • 16. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients.
    Camdessanché JP; Antoine JC; Honnorat J; Vial C; Petiot P; Convers P; Michel D
    Brain; 2002 Jan; 125(Pt 1):166-75. PubMed ID: 11834602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
    Song J; Zhang Y; Lang Y; Wang YH; Shao J; Cui L
    BMC Neurol; 2021 Oct; 21(1):408. PubMed ID: 34702214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiganglioside antibodies in peripheral neuropathies].
    Pardo J
    Neurologia; 2001; 16(7):289-92. PubMed ID: 11485720
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological mechanisms in paraneoplastic peripheral neuropathy.
    Antoine JC
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):61-72. PubMed ID: 11064827
    [No Abstract]   [Full Text] [Related]  

  • 20. Paraneoplastic Limbic Encephalitis Associated with Anti-CV2/CRMP5 Antibodies Secondary to Thymoma in an Adolescent.
    Ibrahim Ismail I; K John J; Ibrahim M; Al-Hashel JY
    Case Rep Neurol; 2020; 12(1):50-55. PubMed ID: 32110228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.